Semaglutide Pen Injector Clinical Trials
9 recruitingDrug
Phase 25Phase 42Phase 32Phase 11
Showing 1–9 of 9 trials
Recruiting
Phase 1Phase 2
Feasibility of Semaglutide in Advanced Lung Disease
ObesityChronic Obstructive Pulmonary DiseaseInterstitial Lung Disease+2 more
University of Pennsylvania8 enrolled1 locationNCT05746039
Recruiting
Phase 3
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
Diabetes Mellitus, Type 1
University of Colorado, Denver60 enrolled2 locationsNCT05819138
Recruiting
Phase 4
JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity
Obesity (Disorder)
McMaster University74 enrolled1 locationNCT06852391
Recruiting
Phase 2
GLP-1R Agonist Treatment for Opioid Use Disorder
Milton S. Hershey Medical Center200 enrolled3 locationsNCT06548490
Recruiting
Phase 4
Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy
Prostate Cancer
Hamilton Health Sciences Corporation20 enrolled1 locationNCT06908694
Recruiting
Phase 2
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
NAFLD
Virginia Commonwealth University50 enrolled1 locationNCT05424003
Recruiting
Phase 2
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver DiseaseImpaired Glucose ToleranceType 2 Diabetes Mellitus+1 more
Yale University60 enrolled1 locationNCT05067621
Recruiting
Phase 2
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
ObesityDiabetes type1
Yale University54 enrolled1 locationNCT06411210
Recruiting
Phase 3
Semaglutide for the Treatment of Glucose Intolerance in Women with Prior Gestational Diabetes
Glucose Intolerance After a Recent History of Gestational Diabetes
Universitaire Ziekenhuizen KU Leuven252 enrolled13 locationsNCT05569772